HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Lorenzo Spaggiari Domenico Galetta Francesco Leo Roberto Gasparri Francesco Petrella Alessandro Borri Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Spaggiari, L. Articles by Venturino, M. Search for Related Content PubMed PubMed Citation Articles by Spaggiari, L. Articles by Venturino, M. Related Collections Lung - cancer Great vessels

J Thorac Cardiovasc Surg 2006;131:490-491
© 2006 The American Association for Thoracic Surgery

Brief Communication

Superior vena cava replacement for lung cancer using a heterologous (bovine) prosthesis: Preliminary results

^a Department of Thoracic Surgery, European Institute of Oncology, Milan, Italy
^b Department of Pathology, European Institute of Oncology, Milan, Italy
^c Department of Anesthesiology, European Institute of Oncology, Milan, Italy

Received for publication August 23, 2005; revisions received August 26, 2005; accepted for publication September 9, 2005.

^_* Address for reprints: Lorenzo Spaggiari, MD, PhD, Department of Thoracic Surgery, European Institute of Oncology, via Ripamonti 435, 20141 Milan, Italy (Email: lorenzo.spaggiari@ieo.it).

The first 20% of the full text of this article appears below.

Drs Petrella, Gasparri, Spaggiari, Scanagatta, Veronesi, Galetta, Leo, Borri (left to right)

Superior vena cava (SVC) resection for lung cancer is technically feasible, with encouraging oncologic results when modern selection criteria are used. ¹ However, some questions still remain, mainly those regarding which type of prosthetic replacement to use after complete SVC substitution. We successfully experimented with a new revascularization technique for SVC replacement after its complete resection for lung cancer, using a heterologous (bovine) custom-made pericardial prosthesis, and we report the early outcome (oncologic and graft patency results) of a preliminary consecutive series.

Clinical Summary

From 1998, 70 patients underwent SVC system resection for lung and mediastinal malignancies: 34 (49%) received prosthetic replacement, and of these, the last 5 patients underwent SVC revascularization with a heterologous (bovine) custom-made pericardial prosthesis.

The surgical approach used was either a large muscle–sparing lateral thoracotomy in the anterior fourth rib section (n = 4) or a right hemiclamshell approach (n = 1). After radical lymph node dissection and before lung resection, . . . [Full Text of this Article]

This article has been cited by other articles:

				J. Y. Perentes, C. C. Erling, H.-B. Ris, J.-M. Corpataux, and L. Magnusson A simple bypass technique for superior vena cava reconstruction Interact CardioVasc Thorac Surg, January 1, 2011; 12(1): 15 - 19. [Abstract] [Full Text] [PDF]

				D. Galetta and L. Spaggiari Reply to the editor. J. Thorac. Cardiovasc. Surg., December 1, 2007; 134(6): 1601 - 1602. [Full Text] [PDF]

				F. Rea, G. Marulli, and F. Sartori Superior vena cava replacement for lung cancer using a heterologous (bovine) prosthesis: Preliminary results J. Thorac. Cardiovasc. Surg., February 1, 2007; 133(2): 592 - 592. [Full Text] [PDF]